Effective management of DKD hinges on controlling blood glucose and blood pressure, blocking the renin-angiotensin-aldosterone system (RAAS) with a single agent are cornerstones of treating DKD (de Boer et al., 2020; Lytvyn et al., 2020). This evidence concerns the gene REN and diabetic kidney disease.